News

The latest news from British Patient Capital

Press release 04 November 2024

British Patient Capital – Full Year Results for the period ending 31 March 2024

Driving long-term growth: British Patient Capital’s total fund and co-investment commitments reach £2.3 billion, retaining its position as the UK’s largest domestic investor in venture and venture growth capital. Total assets under management have now reached £3.125 billion.

Read Press release

Filter news

Showing 61 - 70 of 89 results

Sort by:

British Patient Capital invests in Ultraleap’s £60m funding round through Future Fund: Breakthrough

Press release 17 November 2021

British Patient Capital Commits €25m to Nauta Capital’s fifth fund

Press release 02 November 2021

British Patient Capital invests in accuRx, as part of its £27.5m Series B fundraising

Press release 15 September 2021

Future Fund: Breakthrough Now Open for Investor Applications

Press release 20 July 2021

British Patient Capital Invests in Quantexa’s Series D funding round

Press release 13 July 2021

British Patient Capital Launches Life Sciences Investment Programme

Press release 07 July 2021

British Patient Capital Announces $75m Commitment to $680m Balderton Capital Growth fund

Press release 10 June 2021

British Patient Capital Announces Cornerstone Commitment to £110m Amadeus V Technology Fund

Press release 30 April 2021

British Patient Capital Announces Commitment to Abingworth’s latest fund - British Patient Capital

Press release 18 February 2021

British Patient Capital Announces Cornerstone Commitment to Advent Life Sciences’ third fund

Press release 18 February 2021